Document is current
Any future updates will be listed below
-
Authors
Almer, Alyssa G.
Rasmussen, Samuel V. https://orcid.org/0009-0000-6103-4448
Kats, Dina
Svalina, Matthew N.
Cole, Bonnie L.
Khani, Mohammadreza
Chen, Sonja https://orcid.org/0000-0001-6174-8723
Cheshier, Samuel H.
Martin, Bryn A. https://orcid.org/0000-0003-1234-7880
Berlow, Noah E. https://orcid.org/0000-0001-8666-3152
Keller, Charles https://orcid.org/0000-0003-2505-7487
- License Information
-
More Information
Article History
Received: 22 April 2024
Accepted: 16 May 2025
First Online: 28 May 2025
Competing interests
: C.K. has or has had sponsored research agreements with Eli Lily, Roche-Genentech, and Cardiff Oncology, as well as research collaborations with Novartis, and is co-founder of Tio Companies and Teo Therapeutics. Artisan Biopharma is a wholly owned subsidiary of cc-TDI. B.A.M. is an employee of Alcyone Therapeutics and has been a scientific advisory board member for Novoron Biosciences, Alcyone Lifesciences, Anuncia Medical, Chiari and Syringomyelia Foundation, The International Society for Hydrocephalus and CSF Disorders, and The International CSF Dynamics Society. B.A.M. has received sponsored research funding from NIH, NASA, Biogen Inc., Genentech Inc., Voyager Therapeutics Inc., KBR Wyle, Alcyone Lifesciences Inc., and Minnetronix Inc. B.A.M. has served as a consultant to Flux Neuroscience, Genentech, Roche, Minnetronix, SwanBio Therapeutics, Praxis Medicines, Cerebral Therapeutics, CereVasc, InviCRO, Neurosyntec, Behavior Imaging, Anuncia Medical, and Voyager Therapeutics. All other authors declare no competing interests.
